Colorectal cancer, hereditary nonpolyposis, type 2
- Synonyms
- COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2; Hereditary non-polyposis colorectal cancer, type 2; Lynch syndrome II; MLH1-Related Lynch Syndrome
Summary
Available tests
Check Related conditions for additional relevant tests.
Clinical tests (126 available)
Molecular Genetics Tests
- Mutation scanning of the entire coding region (3)
- RNA analysis (5)
- Targeted variant analysis (16)
- Deletion/duplication analysis (89)
- Sequence analysis of the entire coding region (103)
- Methylation analysis (3)
- Microsatellite instability testing (MSI) (2)
- Mutation scanning of select exons (6)
- Sequence analysis of select exons (4)
Clinical features
Help- Abnormality of the digestive system
- Colon cancer
Colon cancer
- MedGen UID: 2839
- Concept ID: C0007102
- Finding: Neoplastic Process
Abnormality of the digestive system
- Colon cancer
- AMA/NCHPEG, 2012
- NCI PDQ, Genetics of Colorectal CancerGenetics of Colorectal Cancer (PDQ®): Health Professional Version
- NCI PDQ, Breast and Gynecologic CancersGenetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version
- NCI PDQ, Cancer Genetics CounselingCancer Genetics Risk Assessment and Counseling (PDQ®): Health Professional Version
- NCCN, 2024NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024
- NICE, 2020UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020
- ACMG ACT, 2019American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019
- SGO, 2014Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer
- ACMG ACT, 2012American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.